Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Patricia van Velzen"'
Autor:
Leila N. Atmowihardjo, Job R. Schippers, Mark E. Haaksma, Marry R. Smit, Harm J. Bogaard, Leo Heunks, Nicole P. Juffermans, Marcus J. Schultz, Henrik Endeman, Patricia van Velzen, Pieter R. Tuinman, Jurjan Aman, Lieuwe D. J. Bos
Publikováno v:
The Ultrasound Journal, Vol 15, Iss 1, Pp 1-11 (2023)
Abstract Background Lung ultrasound (LUS) can detect pulmonary edema and it is under consideration to be added to updated acute respiratory distress syndrome (ARDS) criteria. However, it remains uncertain whether different LUS scores can be used to q
Externí odkaz:
https://doaj.org/article/d474e83ef80d45cc9a8302595f1e262f
Autor:
Leila N. Atmowihardjo, Job R. Schippers, Erik Duijvelaar, Imke H. Bartelink, Pierre M. Bet, Noortje E. L. Swart, Nienke van Rein, Keith Purdy, David Cavalla, Andrew McElroy, Sarah Fritchley, Anton Vonk Noordegraaf, Henrik Endeman, Patricia van Velzen, Matty Koopmans, Harm Jan Bogaard, Leo Heunks, Nicole Juffermans, Marcus J. Schultz, Pieter R. Tuinman, Lieuwe D. J. Bos, Jurjan Aman
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-13 (2023)
Abstract Purpose A hallmark of acute respiratory distress syndrome (ARDS) is hypoxaemic respiratory failure due to pulmonary vascular hyperpermeability. The tyrosine kinase inhibitor imatinib reversed pulmonary capillary leak in preclinical studies a
Externí odkaz:
https://doaj.org/article/9b66fd0c759d40f6b53c6782c1837294
Autor:
Laura A Buiteman-Kruizinga, Ary Serpa Neto, Michela Botta, Stephanie S List, Ben H de Boer, Patricia van Velzen, Philipp Karl Bühler, Pedro D Wendel Garcia, Marcus J Schultz, Pim L J van der Heiden, Frederique Paulus, INTELLiPOWER–investigators
Publikováno v:
PLoS ONE, Vol 19, Iss 7, p e0307155 (2024)
IntroductionMechanical power of ventilation, a summary parameter reflecting the energy transferred from the ventilator to the respiratory system, has associations with outcomes. INTELLiVENT-Adaptive Support Ventilation is an automated ventilation mod
Externí odkaz:
https://doaj.org/article/205d1e982f9f4c509660c74043a27805
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Publikováno v:
ERJ Open Research, Vol 6, Iss 2 (2020)
Externí odkaz:
https://doaj.org/article/6f8aa8ee27644d0da474cb1f481df437
Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Publikováno v:
ERJ Open Research, 6(2). European Respiratory Society
ERJ open research, 6(2):00099, 1-4. European Respiratory Society
ERJ Open Research, Vol 6, Iss 2 (2020)
ERJ Open Research
article-version (VoR) Version of Record
ERJ open research, 6(2):00099, 1-4. European Respiratory Society
ERJ Open Research, Vol 6, Iss 2 (2020)
ERJ Open Research
article-version (VoR) Version of Record
Most patients with chronic obstructive pulmonary disease (COPD) experience exacerbations [1]. >80% of the exacerbations are treated ambulatorily. Treatment consists of inhaled bronchodilator therapy and oral corticosteroids, whereas the contribution
Autor:
Jan M. Prins, Judith E. Bosmans, Patricia van Velzen, Gerben ter Riet, Peter J. Sterk, Aureliano Paolo Finch
Publikováno v:
PharmacoEconomics, 37(5), 689-699. Adis International Ltd
Finch, A P, van Velzen, P, Ter Riet, G, Sterk, P J, Prins, J M & Bosmans, J E 2019, ' Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD : A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial ', PharmacoEconomics, vol. 37, no. 5, pp. 689-699 . https://doi.org/10.1007/s40273-018-0756-9
Finch, A P, van Velzen, P, Ter Riet, G, Sterk, P J, Prins, J M & Bosmans, J E 2019, ' Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD : A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial ', PharmacoEconomics, vol. 37, no. 5, pp. 689-699 . https://doi.org/10.1007/s40273-018-0756-9
BACKGROUND: Most patients with mild to severe chronic obstructive pulmonary disease (COPD) experience exacerbations, which are also associated with increased healthcare costs. Despite limited evidence of antibiotics' benefits for exacerbations in out
Autor:
Michela Botta, Anissa M Tsonas, Janesh Pillay, Leonoor S Boers, Anna Geke Algera, Lieuwe D J Bos, Dave A Dongelmans, Marcus W Hollmann, Janneke Horn, Alexander P J Vlaar, Marcus J Schultz, Ary Serpa Neto, Frederique Paulus, Jesse P. van Akkeren, Cheetel K. Algoe, Rombout B. van Amstel, Onno L. Baur, Pablo van de Berg, Alida E. van den Berg, Dennis C.J.J. Bergmans, Dido I. van den Bersselaar, Freke A. Bertens, Alexander J.G.H. Bindels, Milou M. de Boer, Sylvia den Boer, Leonoor S. Boers, Margriet Bogerd, Lieuwe D.J. Bos, Jennifer S. Breel, Hendrik de Bruin, Sanne de Bruin, Caro L. Bruna, Laura A. Buiteman-Kruizinga, Olaf L. Cremer, Rogier M. Determann, Willem Dieperink, Dave A. Dongelmans, Hildegard S. Franke, Michal S. Galek-Aldridge, Mart J. de Graaff, Laura A. Hagens, Jasper J. Haringman, Sebastiaan T. van der Heide, Pim L.J. van der Heiden, Nanon F.L. Heijnen, Stephan J.P. Hiel, Lotte L. Hoeijmakers, Liselotte Hol, Markus W. Hollmann, Marga E. Hoogendoorn, Robrecht van der Horst, Evy L.K. Ie, Dimitri P. Ivanov, Nicole Juffermans, Eline Kho, Eline S. de Klerk, Ankie W.M.M. Koopman-van Gemert, Matty Koopmans, Songul Kucukcelebi, Michael A. Kuiper, Dylan W. de Lange, Niels van Mourik, Sunny G.L.H. Nijbroek, Marisa Onrust, Evelien A.N. Oostdijk, Charlotte J. Pennartz, Luigi Pisani, Ilse M. Purmer, Thijs C.D. Rettig, Jan-Paul Roozeman, Michiel T.U. Schuijt, Marcus J. Schultz, Mengalvio E. Sleeswijk, Marry R. Smit, Peter E. Spronk, Willemke Stilma, Aart C. Strang, Anissa M. Tsonas, Pieter R. Tuinman, Christel M.A. Valk, Felicia L. Veen-Schra, Lars I. Veldhuis, Patricia van Velzen, Ward H. van der Ven, Alexander P.J. Vlaar, Peter van Vliet, Peter H.J. van der Voort, Louis van Welie, Henrico J.F.T. Wesselink, Hermien H. van der Wier-Lubbers, Bas van Wijk, Tineke Winters, Wing Yi Wong, Arthur R.H. van Zanten
Publikováno v:
lancet. Respiratory medicine, 9(2), 139-148. Elsevier Limited
The Lancet. Respiratory Medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier
Botta, M, Tsonas, A M, Pillay, J, Boers, L S, Algera, A G, Bos, L D J, Dongelmans, D A, Hollmann, M W, Horn, J, Vlaar, A P J, Schultz, M J, Neto, A S, Paulus, F, van Akkeren, J P, Algoe, C K, van Amstel, R B, Baur, O L, van de Berg, P, van den Berg, A E, Bergmans, D C J J, van den Bersselaar, D I, Bertens, F A, Bindels, A J G H, de Boer, M M, den Boer, S, Boers, L S, Bogerd, M, Bos, L D J, Breel, J S, de Bruin, H, de Bruin, S, Bruna, C L, Buiteman-Kruizinga, L A, Cremer, O L, Determann, R M, Dieperink, W, Dongelmans, D A, Franke, H S, Galek-Aldridge, M S, de Graaff, M J, Hagens, L A, Haringman, J J, van der Heide, S T, van der Heiden, P L J, Heijnen, N F L, Hiel, S J P, Hoeijmakers, L L, Hol, L, Hollmann, M W, Hoogendoorn, M E, van der Horst, R, Ie, E L K, Ivanov, D P, Juffermans, N, Kho, E, de Klerk, E S, Koopman-van Gemert, A W M M, Koopmans, M, Kucukcelebi, S, Kuiper, M A, de Lange, D W, van Mourik, N, Nijbroek, S G L H, Onrust, M, Oostdijk, E A N, Pennartz, C J, Pisani, L, Purmer, I M, Rettig, T C D, Roozeman, J P, Schuijt, M T U, Schultz, M J, Serpa Neto, A, Sleeswijk, M E, Smit, M R, Spronk, P E, Stilma, W, Strang, A C, Tsonas, A M, Tuinman, P R, Valk, C M A, Veen-Schra, F L, Veldhuis, L I, van Velzen, P, van der Ven, W H, Vlaar, A P J, van Vliet, P, van der Voort, P H J, van Welie, L, Wesselink, H J F T, van der Wier-Lubbers, H H, van Wijk, B, Winters, T, Wong, W Y & van Zanten, A R H 2021, ' Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID) : a national, multicentre, observational cohort study ', The Lancet Respiratory Medicine, vol. 9, no. 2, pp. 139-148 . https://doi.org/10.1016/S2213-2600(20)30459-8
The Lancet Respiratory medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory Medicine
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier Ltd.
The Lancet Respiratory Medicine, 9(2), 139-148. Elsevier Limited
The Lancet Respiratory Medicine
The Lancet. Respiratory Medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier
Botta, M, Tsonas, A M, Pillay, J, Boers, L S, Algera, A G, Bos, L D J, Dongelmans, D A, Hollmann, M W, Horn, J, Vlaar, A P J, Schultz, M J, Neto, A S, Paulus, F, van Akkeren, J P, Algoe, C K, van Amstel, R B, Baur, O L, van de Berg, P, van den Berg, A E, Bergmans, D C J J, van den Bersselaar, D I, Bertens, F A, Bindels, A J G H, de Boer, M M, den Boer, S, Boers, L S, Bogerd, M, Bos, L D J, Breel, J S, de Bruin, H, de Bruin, S, Bruna, C L, Buiteman-Kruizinga, L A, Cremer, O L, Determann, R M, Dieperink, W, Dongelmans, D A, Franke, H S, Galek-Aldridge, M S, de Graaff, M J, Hagens, L A, Haringman, J J, van der Heide, S T, van der Heiden, P L J, Heijnen, N F L, Hiel, S J P, Hoeijmakers, L L, Hol, L, Hollmann, M W, Hoogendoorn, M E, van der Horst, R, Ie, E L K, Ivanov, D P, Juffermans, N, Kho, E, de Klerk, E S, Koopman-van Gemert, A W M M, Koopmans, M, Kucukcelebi, S, Kuiper, M A, de Lange, D W, van Mourik, N, Nijbroek, S G L H, Onrust, M, Oostdijk, E A N, Pennartz, C J, Pisani, L, Purmer, I M, Rettig, T C D, Roozeman, J P, Schuijt, M T U, Schultz, M J, Serpa Neto, A, Sleeswijk, M E, Smit, M R, Spronk, P E, Stilma, W, Strang, A C, Tsonas, A M, Tuinman, P R, Valk, C M A, Veen-Schra, F L, Veldhuis, L I, van Velzen, P, van der Ven, W H, Vlaar, A P J, van Vliet, P, van der Voort, P H J, van Welie, L, Wesselink, H J F T, van der Wier-Lubbers, H H, van Wijk, B, Winters, T, Wong, W Y & van Zanten, A R H 2021, ' Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID) : a national, multicentre, observational cohort study ', The Lancet Respiratory Medicine, vol. 9, no. 2, pp. 139-148 . https://doi.org/10.1016/S2213-2600(20)30459-8
The Lancet Respiratory medicine, 9(2), 139-148. ELSEVIER SCI LTD
The Lancet. Respiratory Medicine
The Lancet. Respiratory medicine, 9(2), 139-148. Elsevier Ltd.
The Lancet Respiratory Medicine, 9(2), 139-148. Elsevier Limited
The Lancet Respiratory Medicine
Background: Little is known about the practice of ventilation management in patients with COVID-19. We aimed to describe the practice of ventilation management and to establish outcomes in invasively ventilated patients with COVID-19 in a single coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceb49ed3f5dbc71da01885fe1771742e
https://pure.amc.nl/en/publications/ventilation-management-and-clinical-outcomes-in-invasively-ventilated-patients-with-covid19-proventcovid-a-national-multicentre-observational-cohort-study(46a37e67-7c55-40c3-a572-4d55fd0af420).html
https://pure.amc.nl/en/publications/ventilation-management-and-clinical-outcomes-in-invasively-ventilated-patients-with-covid19-proventcovid-a-national-multicentre-observational-cohort-study(46a37e67-7c55-40c3-a572-4d55fd0af420).html
Autor:
René E. Jonkers, Arjan Rudolphus, Peter J. Sterk, Karin Pool, Patricia van Velzen, Bob T J van den Berg, Jan W.K. van den Berg, Gerben ter Riet, Jan M. Prins, Jeroen J Baars, Dewi R G L Groeneveld-Tjiong, Paul Brinkman, Frans H Krouwels, Coen van Kan, Jennece W F Dagelet, Johannes M.A. Daniels, Paul Bresser
Publikováno v:
lancet. Respiratory medicine, 5(6), 492-499. Elsevier Limited
van Velzen, P, ter Riet, G, Bresser, P, Baars, J J, van den Berg, B T J, van den Berg, J W K, Brinkman, P, Dagelet, J W F, Daniels, J M A, Groeneveld-Tjiong, D R G L, Jonkers, R E, van Kan, C, Krouwels, F H, Pool, K, Rudolphus, A, Sterk, P J & Prins, J M 2017, ' Doxycycline for outpatient-treated acute exacerbations of COPD : a randomised double-blind placebo-controlled trial ', The Lancet Respiratory Medicine, vol. 5, no. 6, pp. 492-499 . https://doi.org/10.1016/S2213-2600(17)30165-0
The Lancet Respiratory Medicine, 5(6), 492-499. Elsevier Limited
van Velzen, P, ter Riet, G, Bresser, P, Baars, J J, van den Berg, B T J, van den Berg, J W K, Brinkman, P, Dagelet, J W F, Daniels, J M A, Groeneveld-Tjiong, D R G L, Jonkers, R E, van Kan, C, Krouwels, F H, Pool, K, Rudolphus, A, Sterk, P J & Prins, J M 2017, ' Doxycycline for outpatient-treated acute exacerbations of COPD : a randomised double-blind placebo-controlled trial ', The Lancet Respiratory Medicine, vol. 5, no. 6, pp. 492-499 . https://doi.org/10.1016/S2213-2600(17)30165-0
The Lancet Respiratory Medicine, 5(6), 492-499. Elsevier Limited
Summary Background Antibiotics do not reduce mortality or short-term treatment non-response in patients receiving treatment for acute exacerbations of COPD in an outpatient setting. However, the long-term effects of antibiotics are unknown. The aim o
Publikováno v:
C33. CLINICAL PROFILES AND SEVERITY OF ASTHMA.
Publikováno v:
B93. COPD EXACERBATIONS: IMPACT OF BACTERIAL AND VIRAL INFECTIONS.